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Abstract
Propionibacterium acnes induction of IL-1 cytokines through the NLRP3 inflammasome was 
recently highlighted as a dominant etiological factor for acne vulgaris. Therefore, therapeutics 
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targeting both the stimulus and the cascade would be ideal. Nitric oxide (NO), a potent biological 
messenger, has documented broad-spectrum antimicrobial and immunomodulatory properties. To 
harness these characteristics to target acne, we utilized an established nanotechnology capable of 
generating/releasing nitric oxide over time (NO-np). P. acnes was found to be highly sensitive to 
all concentrations of NO-np tested, though human keratinocyte, monocyte, and embryonic zebra 
fish assays revealed no cytotoxicity. NO-np significantly suppressed IL-1β, TNF-α, IL-8 and IL-6 
from human monocytes and IL-8 and IL-6 from human keratinocytes respectively. Importantly, 
silencing of NLRP3 expression by small interfering RNA did not limit NO-np inhibition of IL-1 β 
secretion from monocytes, and neither TNF-α, nor IL-6 secretion nor inhibition by NO-np was 
found to be dependent on this pathway. The observed mechanism by which NO-np impacts IL-1β 
secretion was through inhibition of caspase-1 and IL-1β gene expression. Together, these data 
suggest that NO-np can effectively prevent P. acnes induced inflammation by both clearing the 
organism and inhibiting microbial stimulation of the innate immune response.
Introduction
Acne's multifactorial etiology, resulting from a mix of hormone-induced elevations in sebum 
production, abnormal follicular epithelial desquamation and proliferation, hypercolonization 
of Propionibacterium acnes and host inflammatory reactions, make treatment often times 
challenging (Castro and Ferreira, 2008; Zouboulis et al., 2005). This challenge has fueled 
the development of innovative delivery platforms that improve delivery and efficacy of 
established and investigative agents. Various particulate delivery platforms have been 
evaluated for use in acne, including liposomes and nanoparticles. These carriers have the 
advantage of gradual release (Manconi et al., 2002), minimizing irritancy (Manconi et al., 
2002), follicular targeting/enhanced follicular penetration (Jung et al., 2006), and cutaneous 
retention of the active ingredient (Manconi et al., 2006). More importantly, the unique 
properties conferred by the vehicles existing at the nanoscale are allowing for the 
investigation of new therapeutics which in their bulk form can not be delivered topically due 
to stability and solubility issues, including lauric acid (Nakatsuji et al., 2009) and chitosan 
(Friedman et al., 2013).
Along this vein, nanoparticle platforms can be a vehicle through which unstable 
therapeutically relevant agents are harnessed. Nitric oxide (NO) represents one such 
molecule - a diatomic, lipophilic gaseous molecule with functions described ranging from 
vascular modulation to cell cycle regulation, pro- and anti-inflammatory properties, and 
microbicidal/static activity (Friedman and Friedman, 2009). The simplicity of NO mixed 
with its biological potency and complexity makes it an extremely promising 
pharmacological agent, but utilization has been limited due to the lack of effective and safe 
delivery systems. We previously reported on a hybrid hydrogel-sugar based nanoparticulate 
system (np) capable of generating physiologic concentrations of NO over time. Upon 
exposure to an aqueous environment, the hydrogen bonding network that comprises the 
nanoparticle matrix loosens, allowing release of the NO. (Friedman et al., 2008b; Han et al., 
2011). This platform is unique in that nanoparticle matrix facilitates the generation of nitric 
oxide from encapsulated sodium nitrite through a dinitrogen trioxide intermediate, as the 
rich disulfide bonding network allows for long range proton and electron transfer/
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movement. As opposed to organic nitrates, the most commonly used NO-donor in clinical 
practice, there is no potential for decreased efficacy with prolonged and continuous use, 
what is known as ‘nitrite tolerance,’ which results from the prerequisite host reduction of the 
administered nitrate to active nitric oxide (Bennett et al., 1994; Gori and Parker, 2002).
We have previously shown that NO-np significantly increase the healing of MRSA infected 
wounds in a murine excisional injury model (Martinez et al., 2009). NO-np also accelerated 
wound healing in non-obese, diabetic, severe combined immunodeficiency mice, with 
significantly decreased neutrophil and increased macrophage infiltration noted in the NO-np 
treated wound beds as compared to another topical NO-donating platform, 
diethylenetriamine (Blecher et al., 2012). Given the antimicrobial and immunological 
properties of NO, we investigated whether NO-np has antimicrobial activity against 
Propionibacterium acnes, and modifies the inflammatory cascade associated with the 
evolution of acne lesions.
Results
Characterization of nanoparticles, detection of NO release, and tissue penetration
Nitric oxide nanoparticles were formed using a previously described protocol (Friedman et 
al., 2008). In brief, the highly anhydrous interior of the nanoparticles facilitates the 
formation of N2O3 from nitrite and protons. N2O3 is both the source of NO and is a potent 
S-nitrosating agent that likely contributes to the biological efficacy of NO-np.
Using scanning electron microscopy (SEM), NO-nanoparticle aggregates were found to 
average approximately 127 nm in diameter (Figure 1a). We have previously shown by 
transmission EM that individual particles measure ∼10 nm in diameter (Friedman et al., 
2008). Using Dynamic light scattering (DLS), NO-np revealed an average hydrodynamic 
diameter of 216.9 nm based on 40 acquisition attempts (Figure 1b). The standard deviation 
was 14.2 nm (3.3%), proving that NO-np are homogenous in size. Since NO-np swell with 
moisture, the average diameter is likely an overestimate as compared to the SEM. NO 
release from the NO-np has been previously reported using both amperometric detection and 
ozone chemiluminescence (Cabrales et al., 2010; Friedman et al., 2008).
Antimicrobial activity of NO-np
NO generated from the NO-np has demonstrated antimicrobial activity against various Gram 
positive and negative pathogens, including Staphylococcus aureus (Martinez et al., 2009) 
and Pseudomonas aeruginosa (Friedman et al., 2011), and therefore we sought to evaluate 
the impact on P. acnes.
P. acnes strains were incubated with various concentrations of NO-np and np (0.625, 1.25, 
2.5, or 5 mg/mL) for 24 h (Figure 2a). For all isolates tested, all concentrations of NO-np 
significantly inhibited bacterial growth compared to controls in a dose-dependent manner for 
up to 24 h. Concentrations over 2.5 mg/ml completely inhibited growth over 24 hours while 
1.25 and 2.5 mg/ml significantly inhibited growth after 24 hours of co-incubation 
respectively (p<0.0001) as compared to all controls as well as 0.625 mg/ml NO-np. 
Statistical significance was not met when comparing the two treatment groups (p=0.07). To 
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demonstrate the bactericidal activity against P. acnes, bacteria was incubated with varying 
doses of NO-np, as well as np control alone for 4 hours. Subsequently, the bacteria were 
plated and the viability was determined by colony-forming unit (CFU) assay. The NO-np 
were effective at significantly killing P. acnes, resulting in only 8.9% and 4.6% survival for 
the two concentrations illustrated (Fig. 2b). Interestingly, the 2.5 and 5 mg/ml np control had 
a modest, albeit significant effect, compared to untreated cells, likely owing to the physical 
presence of the nanoparticles that probably imparted a steric effect, interfering with cell-cell 
interactions, noted in previous investigations (Friedman et al., 2011).
NO-np inhibit P. acnes stimulated inflammatory cytokines
Given the importance of the inflammatory response in the pathophysiology of acne, we 
evaluated NO's ability to inhibit inflammatory cytokine production from a P. acnes 
challenged human keratinocyte cell line, HaCaT, and peripheral blood mononuclear cells 
(PBMCs). Previous studies showed that P. acnes induces the inflammatory cytokines IL-1, 
IL-8 and IL-12 in human monocytes and IL-6 in human keratinocytes (Friedman et al., 
2013; Qin et al., 2014). At the same concentrations tested in the antimicrobial assays, NO-
np significantly reduced P. acnes stimulated human monocyte (PBMC) expression of IL-1 β 
(52.0% reduction), TNF-α (91.3% reduction) at the highest dose tested (Fig 3a-b). Control 
nanoparticle (np) had no inhibitory effect on IL-1β secretion at all concentrations tested 
(S2). NO-np significantly inhibited P. acnes stimulated PMBC and HaCaT IL-6 and IL-8 
secretion in a dose dependent manner as compared to controls (Fig 3c-f). For IL-6 and IL-8 
secretion respectively, a statistically significant difference was noted when comparing 
control to 2.5 mg/ml (33.4% and 54.84% reduction) and 5mg/ml (54.8% and 88.47% 
reduction) for the PBMC group and to all treatment groups with the HaCaT cells (15.1%, 
51.5%, and 65.0% and 48.31%, 90.76%, and 98.93% respectively).
With the recent attention paid to IL-1β as the initial subclinical stimulus for follicular 
hyperkeratinization, its place in and importance of the NLRP3 inflammasome with respect 
to P. acnes induction of the host defense (Qin et al., 2014), we sought to determine if the 
aforementioned anti-inflammatory effects resulted from NO-np's impact on this multi-
protein complex. To evaluate whether NO-np reduction of IL-1β, IL-6, and TNF-α secretion 
was mediated specifically through NO activity on NLRP1 and/or NLRP3, small interfering 
RNA (siRNA) were utilized silence specific gene expression as previously described (Qin et 
al., 2014). Transfection of monocytes with specific siRNA targeting NLRP3 resulted in a 
significant reduction of IL-1 β expression (93.8%, p<0.01) (Fig 4a), as compared to 
stimulated controls, respectively. A nonspecific control siRNA had no effect in all cases. 
While siNLRP3 transfection of PBMCs resulted in a 93.8% reduction in IL-1β secretion, 
NO-np treatment provided further, statistically significant reduction (>99%) as compared to 
stimulated siNLRP3 control. In congruence with past results, siNLRP1 transfection of 
PBMCs resulted in minimal reduction in P. acnes induced IL-1 β secretion, while a 55.27% 
reduction in IL-1 β expression following NO-np treatment compared to untreated was noted. 
Interestingly, knockout of NLRP3 did not influence P. acnes stimulated secretion of IL-6, 
IL-8 nor TNF-α from PMBCs, and NO-np treatment yielded similar reductions in cytokine 
secretion as noted above (S1a-c). However, knockdown of NLRP1 had a significant effect in 
NO-np inhibition of IL-6 secretion from PBMCs as compared to NLRP3 knockdown.
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NO-np inhibit P. acnes induced Caspase-1 and IL-1 β, but not NLRP3, gene expression
Given the additional reduction of IL-1 β secretion from siNLRP3 transfected PBMC beyond 
the effects of knockdown alone, we sought to evaluate NO-np activity on gene expression of 
key inflammasome components. IL-1β and caspase-1 mRNA levels were significantly 
reduced in PBMCs exposed to P. acnes and treated with NO-np as compared to controls 
(87.1% and 80.0% reduction, respectively; Fig 4a-b), with an associated decrease in 
caspase-1 production and activity (Fig 5a-b). NO-np treatment had minimal effect on both 
NLRP3 and ASC mRNA expression as compared to controls (Fig 4d-e). NO-np alone did 
cause a slight but significant increase in IL-1β mRNA expression.
NO-np are non-toxic
All concentrations of NO-np tested had minimal toxicity to keratinocytes and PBMCs using 
MTT assay (p=0.31 and 0.13, respectively, as compared to control) (Fig 6a-b), which was 
further substantiated using embryonic zebra fish assays (Fig 6c). The embryonic zebrafish 
assay was used to assess the toxicological impact of NO-np in an in vivo vertebrate model 
system. Embryos exposed to NO-nps did not exhibit differences in rates of malformations or 
mortality at any concentration tested compared to controls. Any differences in morphology, 
mortality, development, larval morphology, or behavioral endpoints between treatment and 
control were attributed to laboratory background. Therefore, our data suggest that NO-nps 
can inhibit P. acnes-induced cytokine production in human keratinocytes and PBMCs, and 
this is not a consequence of the release of cytokines at cell death.
Discussion
In this work, we demonstrated that the NO-nps effectively decreased P. acnes viability and 
inhibited IL-1β, TNF-α, IL-8 and IL-6 secretion from P. acnes stimulated PMBCs and IL-8 
and IL-6 from keratinocytes, while neither having in vitro nor in vivo cytotoxicity. While 
NO-np was found to impact components of the NLRP3 inflammasome pathway, its anti-
inflammatory effects were not specific to NLRP3, and NLRP3 knockout did not impair NO-
np's anti-inflammatory properties.
Nearly every member of the skin cell population expresses nitric oxide synthase (NOS) and 
is thereby able to produce NO to accomplish key physiologic processes. NO's role in skin 
host defense is concentration-dependent, and is imparted in a bimodal fashion. At low 
concentrations it stimulates the immune system by enhancing immune cell activity, cytokine 
production, expression of adhesion factors, and extracellular matrix constituent synthesis. 
High-output of endogenous NO is achieved through the stimulation of pathogen recognition 
receptors that promote iNOS transcription and subsequent L-arginine dependent NO release 
(Griffith and Stuehr, 1995). This calcium-independent enzymatic pathway along with 
nonenzymatic reduction of naturally occurring nitrosothiols (RSNO) and nitrate (NO3-) are 
the two key methods of endogenous NO synthesis pertinent to microbial eradication (Weller, 
2009). The coupling of NO and O2- produces potentially toxic reactive nitrogen species 
(RNS), such as the peroxynitrite anion (ONOO-), and induces increased O2- production 
(Fang, 2011). RNS's can interfere with normal protein interactions as protein thiols become 
nitrosated (Han et al., 2011). Collectively, these molecules adversely affect microbial 
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viability by traversing cellular membranes, interrupting DNA replication, instigating lipid 
peroxidation, and inactivating metalloproteinases essential for microbial metabolism (Wink 
and Mitchell, 1998).
P. acnes, which resides in pilosebaceous follicles in both acne and non-acne subjects, elicits 
an inflammatory responses essential for the pathogenesis and clinical phenotype of acne 
vulgaris (Bellew et al., 2011). P. acnes was found to be highly sensitive to NO derived from 
the NO-np. Perhaps the most significant aspect to be considered of NO's microbicidal 
activity is the lack of demonstrated resistance to date. This is thought to be a direct result of 
the aforementioned multiple mechanisms of NO's action - to overcome would require the 
simultaneous development of distinct resistance mutations. Some minor compensatory 
mechanisms against the actions of NO have been elucidated (Richardson et al., 2008); 
however, no protection against the high concentrations of NO released by donating materials 
is evident. Isolates of S. aureus, Staphylococcus epidermidis, Escherichia coli O157:H7, and 
P. aeruginosa that survived exposure to high NO concentrations showed no increase in 
minimum inhibitory concentration levels afterward (Privett et al., 2012). Given the ongoing 
concern regarding antibiotic resistance in P. acnes, NO-np represents a much needed multi-
mechanistic antimicrobial approach (Eady, 1998; Ross et al., 2003).
While P. acnes is implicated in the pathophysiology of Acne Vulgaris, it serves more as a 
pro-inflammatory stimulus rather then a pathogenic organism, and therefore muting this 
response is central to clinical treatment. We found that NO-np inhibited IL-8 and IL-6 
production from P. acnes stimulated PBMCs and keratinocytes in a dose dependent manner. 
IL-8 is a CXC chemokine that serves as a potent chemoattractant for neutrophils, a 
predominant cell type in acne-related lesions. IL-8 gene expression has been shown to be 
significantly elevated in biopsy specimens of acne lesions (Trivedi et al, 2006). IL-6 is 
pleiotropic cytokine playing an important role in acute and chronic inflammation. IL-6 has 
also been shown to contribute to persistent neutrophil trafficking in wounds, resulting in 
delayed wound healing in the setting of sustained stress (Kim et al, 2014). Interestingly, we 
found that NLRP1 may have a role in NO-np down-regulation of P. acnes induced IL-6 
expression, as compared to NLRP3, warranting further investigation.
NO-np had a profound effect the secretion of TNF-α from PBMCs. TNF-α is central to 
stimulating the acute phase reaction of the immune response. Implicated in multiple 
dermatologic diseases including acne, several studies have highlighted that single nucleotide 
polymorphisms (SNPs) of the TNF-α gene (such as the -308 G/A polymorphism) are 
associated with an increased risk to develop chronic inflammatory disease (Yang et al., 
2014). NO-np significantly inhibited PBMC induction of TNF-α triggered by P. acnes, 
almost completely at the highest concentration tested (5mg/ml).
NO is known to modulate several innate immune pathways, enhancing the host's own 
immune response; for example, NO is involved in lymphocyte activation and proliferation 
and numerous cytokine pathways, including TNF-α, TGF-β, p56, IL-6, and NF-κB (Fang, 
1997). However, while an important recruiter of host defense against invading pathogens, 
NO's immunoregulatory function is clearly multi-faceted - NO can function as an anti-
inflammatory agent when appropriate, as demonstrated in this study. For example, 
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investigators have shown that NO inhibits key members of the inflammatory cascade such as 
NF-κB and STAT-1 in keratinocytes (Giustizieri et al., 2002), and down-regulates 
neutrophil aggregation, secretion and diapedesis (Dal Secco et al., 2003). We too 
demonstrated that NO-np inhibits secretion of various pro-inflammatory cytokines from 
different cell types stimulated with P. acnes.
In light of the recent data highlighting the role of caspase dependent IL-1 β generation 
through the NLRP3 inflammasome pathway in the pathophysiology of acne vulgaris, (Qin et 
al., 2014), we showed that NO-np inhibits P. acnes stimulated PBMC IL-1β and caspase-1 
gene expression, likely explaining the additional reduction in IL-1β secretion from P. acnes 
stimulated siNLRP3 transfected monocytes treated with NO-np. The NLRP3 inflammasome 
is a multi-protein complex that triggers the maturation of the pro-inflammatory cytokines 
IL-1β and IL-18 (Hernandez-Cuellar et al., 2012). This complex can be activated by 
pathogen-associated molecular patterns (PAMPs) or endogenous danger-associated 
molecular patterns (DAMPs) generated in the setting of cellular injury or tissue damage 
(Dostert et al., 2008; Qin et al., 2014; Schroder and Tschopp, 2010). Interestingly, one of 
NO's roles may be as a negative regulator of inflammasome activity. It was previously 
shown that inflammasome activation was inversely correlated to iNOS expression, and that 
NO inhibited IL-1β production and caspase-1 activation (Mao et al., 2013). The mechanism 
by which NO is believed to inhibit the various elements of the inflammasome is via S-
nitrosylation several proteins involved in cellular regulation, ultimately impacting their 
activity and function (Stamler et al., 2001). We demonstrated that NO-np did not reduce 
gene expression of NLRP3, however this finding does not provide insight into NLRP3 
activity or degree of nitrosylation. We have previously shown that the NO-np are effective 
trans-nitrosating agents (Friedman et al., 2011), likely owing to the nanoparticles' forming a 
dinitrogen trioxide intermediate, capable of S-nitrosation under aerobic and anaerobic 
conditions, which therefore offers a mechanism for the observed activity.
Regardless of NLRP3 function, we demonstrated NLRP3 independent anti-inflammatory 
effects in a NLRP3 knockdown model, likely owing but not limited to NO-np's direct effect 
on caspase-1 and IL-1 β gene expression. This finding has far reaching implications in many 
disease states given the broad role of both in all inflammasome pathways. Interestingly, 
knockdown of NLRP3 did not impact NO-np suppression of P. acnes stimulated monocyte 
derived IL-6, IL-8, and TNF-α, once again supporting NO's multi-mechanistic anti-
inflammatory activity and highlighting NO's target diversity.
Not surprisingly, we found that NO-np alone mildly induces PBMC IL-1β expression in the 
absence of pathogen stimulus, highlighting the duality of NO's functions in immune 
regulation. We and other investigators have shown that at low concentrations, NO stimulates 
PMBC generation of IL-6, but as NO levels increased using NO-donor molecules, both IL-6 
expression and NF-κB activity decreased. A greater degree of nitrosative stress increases the 
likelihood of protein S-nitrosylation, in this case, of key NF-κB related proteins including 
IκB kinase b and p50, which was shown to directly inhibit pro-inflammatory activity 
(Marshall et al., 2004). This further supports any NO releasing technology that facilitates 
trans-nitrosylation. Therefore, the current theory is that in the early stage of infection, lower, 
initial concentrations of NO may accelerate the immune response by stimulating the 
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synthesis of proinflammatory cytokines, while at a later stage, when NO concentrations have 
peaked and cells are activated, it rather counteracts the undesired development of 
inflammation.
Together, the presented and past data demonstrating that NO-np have multi-mechanistic 
antimicrobial and anti-inflammatory properties, suggest that NO-np can potentially target 
multiple pathophysiologic elements of Acne Vulgaris. Importantly, in the face of rising of 
antimicrobial resistance in the setting of prolonged antibiotic use, NO's bactericidal and 
static properties limit the risk of the emergence of resistant species. Therefore, our findings 
suggest that the NO-np offers a new approach to harness the therapeutic potential of nitric 
oxide, and that this platform should be translated to the bedside.
Materials and Methods
Production of NO-np
The production of the NO-np has been previously reported (Friedman et al., 2008). Briefly, 
the NO-np are prepared using the following sequence of steps: 1) Hydrolyzing 
Tetramethylorthosilicate (TMOS): Stock of 5 ml of TMOS, 600 μl of deioinized water, 
and 560 μl of 2 mM hydrochloric acid are added to a small vial. The contents of the vial are 
sonicated for approximately 20-30 minutes yielding a clear solution that is then placed on 
ice. 2) Mixing the sol-gel components: 1.49 g of sodium nitrite are dissolved in 4 ml of 
PBS buffer at pH 7.5 followed by sequential addition and mixing of 0.5 ml of PEG-200, 
500μl of chitosan (1mg/ml). The resulting mixture is then vortexed thoroughly. Then, 2 ml 
of previously hydrolyzed TMOS is added to the solution followed by vigorous vortexing 
until complete gelation. 3) Lyophilizing the sol-gel: The resulting gelled material is then 
lyophilized for 24-48 hrs that removes all volatile components. 4) Ball-Milling the 
lyophilized sol-gel: Following lyophilization the dry material is ball milled at 150 rpm for 8 
hours resulting in a very fine white powder.
Nanoparticle Imaging
(Supplemental)
Dynamic light scattering (DLS)
(Supplemental)
Nanoparticle skin penetration
Retired breeder male Sprague-Dawley rats (650 g, Charles River Breeding Laboratories 
(Wilmington, MA, USA)) were used in these studies. All animal protocols were approved 
by the Animal Use Committee at the Albert Einstein College of Medicine. Rats (n=3) were 
first anesthetized via intraperitoneal injection of sodium pentobarbital (35 mg/kg; Abbott 
Laboratory, Chicago, IL, USA). Four aliquots of 50 ul of Alexafluor-594nm labeled NO-np 
(5mg/ml) suspended in coconut oil were applied to the 4 abdominal quadrants of the 
abdomen. Coconut oil alone was used as a control (n=1). After ten minutes, quadrants were 
cleaned with alcohol wipes and 4-mm punch biopsies were taken from each application site. 
Specimens were subjected to frozen sectioning and vertical sections (4 mm thick) were fixed 
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to glass slides. Images were captured with a confocal microscope (PerkinElmer) with a 10×, 
1.4 NA objective and a digital camera (Orca ER; Hamamatsu).
CFU assay and Bioscreen Analysis
P. acnes strain ATCC 6919 was obtained from American Type Culture Collections and 
isolates grown in the miniMACS anaerobic workstation (Don Whitley Scientific, West 
Yorkshire, UK). Briefly, Brucella agar plates supplemented with blood, hemin, and vitamin 
K (Remel Fisher Scientific, Lenexa, KS) were streaked with P. acnes overnight and single 
colonies isolated. The cultures were grown in an anaerobic chamber for 4–5 days. A 
spectrophotometer OD600 was used to determine the bacterial log phase.
Various concentrations of control and NO-nps (0.625, 1.25, 2.5, 5 mg/ml) were incubated 
with 3.75 ×105 bacteria in a final volume of 30 ml at 37°C for 4 hours. After incubation, 10-
fold dilutions were prepared and incubated for 4 days at 37°C under anaerobic conditions. 
Individual colonies were counted and the number of CFU was tabulated.
For growth kinetics, reinforced Clostridium medium was inoculated with a fresh colony 
grown on the Brucella Agar plates and suspended in 1 mL of medium. A suspension of 100 
μL of bacteria was transferred to a 200-well plate with 100 μL of reinforced Clostridium 
medium per well containing NO-np or np (0.625, 1.25, 2.5, 5, mg/mL). Bacteria and 
nanoparticles were incubated for 24 h at 37°C. Controls included wells containing bacteria 
with reinforced Clostridium medium alone. Growth was assessed at OD 600 nm every 30 
min using a microplate reader (Bioscreen C, Growth Curves USA, Piscataway, NJ).
P. acnes culture and cell stimulation
PBMCs were stimulated by P. acnes strain 6919 at MOI 0.5, while HaCaT keratinocytes 
were infected by P. acnes at MOI 20 (Qin et al., 2014). We used live P. acnes as opposed to 
sonicated-killed preparations of P. acnes due to the pathophysiological relevance of our 
model and consistency on the observed responses.
Isolation of Peripheral blood mononuclear cells, HaCaT cell culture and cytokine ELISA
PBMCs were isolated from whole blood of normal healthy donors as approved by the 
Institutional Review Board at UCLA using Ficoll-Paque gradients (GE Healthcare, 
Piscataway, NJ) and plated onto 24-well tissue culture plates (5 × 106 per well) in RPMI 
1640 media containing 10% FBS (HyClone, South Logan, UT). Cells were co-cultured one 
hour with 0 mg/ml, 1.25 mg/ml, 2.5 mg/ml and 5 mg/ml of NO-nanoparticles respectively. 
Then cells were infected by P. acnes at MOI 0.5 for 24 hours at 37°C.
HaCaT cells, an immortalized human keratinocyte cell line, plated into 6-well tissue culture 
plates (5 × 105 per well) and cultured at 37°C with 5% CO2 in Dulbecco's Modified Eagle 
Medium (DMEM) (Gibco11995-060, Invitrogen Corp., USA) supplemented with 10% heat 
inactivated Fetal Bovine Serum (HyClone, South Logan, UT) and 1% Penicillin/
Streptomycin (Gibco 15140-122, Invitrogen Corp., USA) for 18 hours. HaCat cells retain 
their ability to differentiate, to express Toll-like receptors involved in pathogen recognition 
and to produce a number of cytokines in response to bacterial stimulation in a similar 
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manner to Primary human keratinocytes (Grange PA et al, 2009). HaCaT were treated one 
hour with the different doses of NO-nanoparticles as above. Then cells were infected by P. 
acnes at MOI20 for 24 hours at 37°C.
IL-6, IL-8, IL-1β and TNFα levels in culture supernatants were measured by ELISA 
following the manufacturer's recommendations (R&D ELISA Development System, 
Minneapolis, MN). Samples were assayed in triplicates. Results are expressed as mean±SD 
of at least three independent experiments, with PBMCs obtained from three independent 
donors.
RNA isolation, cDNA synthesis, and real-time PCR
(See Supplemental)
siRNA transfection
siRNA transfection into PBMCs was accomplished by using the Amaxa Nucleofector 
system and the Nucleofector Kit according to the manufacturer's recommendations with 
program U-001 for high viability. siRNA constructs (scramble, siNLRP3 and siNLRP1) 
were used at 1 μg per transfection. Transfection efficiency of expression constructs was 
assessed using the pMAX-GFP construct, and it yielded an average of 70% transfection rate 
(Lonza, Allendale, NJ). Transfected cells were plated into 6-well cell culture plates and 
cultured at 37 °C for overnight. Transfected cells were co-cultured with NO-nanoparticle 2.5 
mg/ml for an hour, and then infected by P. acnes at MOI 0.5.
Western Blot analysis
Detection of caspase-1 was performed by western blot analysis. Isolated peripheral blood 
mononuclear cells (PBMC) were treated with 2.5 mg/mL NO-np or control np for an hour. 
Cells were then infected by P. acnes with MOI 0.5. After 24 hours, cells were harvested and 
lysed in 100 μL of lysis buffer (M-PER Mammalian Protein Extraction Reagents, Thermo 
Scientific) with protease inhibitors. Protein levels were normalized with the Bradford assay. 
Protein profiles were separated by electrophoresis in BIO-RAD mini PROTEAN TGX 
polyacrylamide precast gels and transferred onto 0.45 μm Millipore Immobilon P-transfer 
membranes, and caspase-1 was detected by caspase-1 monoclonal antibody (D7F10, Cell 
Signaling). The bands from western blot were visualized by using VersaDOC MP5000 
(BIO-RAD).
Activity Assay
Isolated peripheral blood mononuclear cells (PBMC) were treated with 2.5 mg/mL NO-np 
or control np for an hour. Cells were then infected by P. acnes with MOI 0.5. After 24 
hours, cells were harvested and lysed with 100 μL of cold lysis buffer. Caspase-1 protein 
activity was then measured using Caspase-1 Colorimetric Assay (R&D systems) per 
manufacturer's instructions and the activity was determined via percentage of the control 
(cells alone). After 16 hours of incubation at 37 °C, activity was read using BioTek Synergy 
2 plate reader using a wavelength of 405 nm.
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MTT toxicity assay
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrasodium bro-mide tetrazolium; 
Sigma Aldrich) was performed as previously described (Friedman et al., 2013) (see 
supplemental for complete methods).
Statistical analysis
GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA) was used for statistical analyses. p 
val- ues were determined by analysis of variance and adjusted by use of the Bonferroni 
correction. p values of <0.05 were considered significant
In vivo toxicity assay
Zebrafish embryos (Danio rerio, wild type, 5D-Tropical strain) were obtained from 
Sinnhuber Aquatic Research Laboratory, Oregon State University, and exposures and 
evaluations were conducted according to Truong et al (Truong et al., 2011). Exposures were 
conducted over 5 days of development. All organ systems begin functioning during this time 
period and all of the molecular signaling pathways are active and necessary for normal 
development to occur. At 120 hpf, behavioral endpoints (motility, tactile response) and 
larval morphology (body axis, eye, snout, jaw, otic vesicle, notochord, heart, brain, somite, 
fin, yolk sac, trunk, circulation, pigment, swim bladder) were evaluated in vivo and scored in 
a binary fashion (present or absent).. Untreated control and exposed groups were compared 
using Fisher's exact test for each endpoint, and p-value < 0.05 for significance.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
NO Nitric Oxide
np nanoparticle
SEM scanning electrom microscopy
MOI multiplicity of infection
NLR nucleotide oligomerization domain-like receptor
PBMC human monocyte
PEG polyethylene glycol
siRNA small interfering RNA
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Figure 1. Nanoparticles Characterization
(a) Scanning electron microscopy revealed distinct spherical nanoparticles with irregular 
surface structure indicative of the porous matrix lattice (scale bar = 100 nm). (b) Using 
Dynamic light scattering (DLS), NO-np revealed an average hydrodynamic radius of 108.47 
nm based on 40 acquisition attempts. The standard deviation was 14.2 nm (3.3%), proving 
that NO-np are homogenous in size.
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Figure 2. Antimicrobial effects of Nitric Oxide releasing nanoparticles
(a) Susceptibility of P. acnes isolates to varying concentrations of empty nanoparticles (np) 
and NO-np (0.625, 1.25, 2.5 and 5 mg/ml), was investigated by real-time Bioscreen analysis 
and (b) colony form unit assay determination (mean CFU per ml). Experiments were 
repeated in triplicate and performed at least thrice on separate days. Asterisks denote p value 
significance calculated by unpaired two-tailed t test analysis. (*, p < 0.05; **, p < 0.01).
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Figure 3. NO-np significantly inhibits P. acnes induced pro-inflammatory cytokines in PMBC 
and keratinocytes
P. acnes stimulated PBMCs expression of IL-1β (a), TNF-α (b), IL-6 (c), and IL-8 (e), and 
HaCaT cell expression of IL-6 (d) and IL-8 (f) with and without various concentrations of 
NO-np. NO-np at 2.5 mg/ml was used as a control. IL-1β and TNF-α were undetectable in 
the HaCaT supernatant via ELISA (data not shown)). The data is presented as the mean of 
triplicate wells ± SD and is representative of three individual experiments. (*, p < 0.05; **, p 
< 0.01).
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Figure 4. NO-np inhibits PBMC IL-1β secretion by directly down-regulating IL-1β gene and 
Caspase-1 gene expression via the inflammasome pathway
Cells were infected by P. acnes at MOI 0.5 with and without NO-np and with scramble 
siRNA, siNLRP3 or siNLRP1, and IL-1β secretion in culture supernatants was tabulated via 
ELISA (NO-np 2.5 mg/ml) (a). The expressions of Caspase-1, IL-1β, NLRP3, and ASC 
were measured by real-time PCR (b-e). Data are shown as the mean of triplicate wells ± SD 
and is representative of three individual experiments. (*, p < 0.05; **, p < 0.01).
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Figure 5. NO-np down-regulates P. acnes induced Caspase-1 protein expression and activity in 
PBMC cells
Peripheral blood mononuclear cells (PBMC) were isolated from whole blood of normal 
healthy donors. Transfected cells were plated into 6–well cell culture plates, cultured at 
37°C overnight, and co-cultured with or without 2.5 mg/mL control-np and 2.5 mg/ml NO-
nanoparticle for an hour. Cells were then infected by P. acnes at MOI 0.5 for 24 hours. Cells 
were lysed, and caspase-1 protein expression was measured with western blot (a) and 
activity assay (b). a) Western blot using anti-caspase-1: Cells alone (Lane 1); P. acnes (Lane 
2); Control np (Lane 3); NO-np (Lane 4); P. acnes in the presence of NO-np (lane 5); P. 
acnes in the presence of Control np (lane 6). b) Caspase-1 activity assay: cells were 
normalized as percentage of control cells. NO-np significantly decreases PBMC caspase-1 
protein activity in the presence of P. acnes compared to control-np. (*, p < 0.05)
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Figure 6. Nitric Oxide releasing Nanoparticles are non-toxic
NO-np at various concentrations (1.25, 2.5 and 5 mg/ml, respectively) were incubated with 
HaCaT cells (a) or PBMCs (b). Cells were collected and evaluated for viability using MTT 
assay. (c) Representative images of zebrafish embryos at 120 hpf: control (top) and exposed 
to NO-np (bottom). No significant differences were observed in larval morphology or 
behavioral endpoints (p > 0.05 for each endpoint evaluated, Fisher's Exact test). Error bars 
denote SEM.
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